MIRTA AGUILAR-RAGBIR: Open Payments
NPI 1285170829 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,511 in 157 payments from 24 companies in 2025. Trend: 2023 $666 · 2024 $4,005 · 2025 $4,511
Food & beverage: $4,332Education: $179
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 33 | $1,232 |
| GlaxoSmithKline, LLC. | 34 | $678 |
| Verona Pharma, Inc. | 23 | $405 |
| United Therapeutics Corporation | 8 | $391 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $348 |
| Grifols USA, LLC | 11 | $180 |
| GENZYME CORPORATION | 3 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $160 |
| ANI Pharmaceuticals, Inc. | 6 | $143 |
| Actelion Pharmaceuticals US, Inc. | 2 | $129 |
Products named: BREZTRI, NUCALA, Ohtuvayre, DUPIXENT, FASENRA, AIRSUPRA, TRELEGY ELLIPTA, Prolastin-C Liquid.
Industry payments across FL — which companies pay providers there.
